GLOBUS MEDICAL INC (GMED) › Cost of RevenueGLOBUS MEDICAL INC (GMED) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $134.71M2017: $150.45M2018: $159.41M2019: $179.97M2020: $217.46M2021: $239.22M2022: $263.73M2023: $548.17M2024: $1.04B2025: $957.80M$957.80M2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$957.80M-7.5%2024$1.04B+88.9%2023$548.17M+107.9%2022$263.73M+10.2%2021$239.22M+10.0%2020$217.46M+20.8%2019$179.97M+12.9%2018$159.41M+6.0%2017$150.45M+11.7%2016$134.71M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share